Efficacy and safety of once daily fluticasone furoate nasal spray for treatment of irritant (non-allergic) rhinitis

Open Respiratory Medicine Journal

Volumn 4, Issue , 2010, Pages 92-99

  Tantilipikorn, Pongsakorn ^a   Thanaviratananich, Sanguansak ^b   Chusakul, Supinda ^c   Benjaponpitak, Suwat ^d   Fooanant, Supranee ^e   Chintrakarn, Chalermchai ^d   Jirapongsananuruk, Orathai ^a   Visitsunthorn, Nualanong ^a   Toler, Tom ^f   Sutton, Laura ^f   Wu, Wei ^f   Lee, Laurie ^f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CHIANG MAI UNIVERSITY   (Thailand)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Fluticasone furoate; Irritant; Rhinitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUTICASONE FUROATE; PLACEBO;

ADULT; AIR POLLUTION; AIR QUALITY; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; CYTOLOGY; DISEASE ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHIL COUNT; EOSINOPHILIA; EPISTAXIS; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRAINE; MULTICENTER STUDY (TOPIC); NOSE OBSTRUCTION; NOSE SEPTUM ULCER; NOSE SMEAR; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PILOT STUDY; PRICK TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLECTIVE TOTAL NASAL SYMPTOM SCORE; REFLECTIVE TOTAL OCULAR SYMPTOM SCORE; SCHOOL CHILD; VASOMOTOR RHINITIS;

EID: 84987736307     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401004010092     Document Type: Article

References (15)

1. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24: 147-54.
2. Druce H. Allergic and nonallergic rhinitis. In: Middleton E, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger W, Busse WW, Eds. Allergy principles and practice. 5th ed. St Louis: Mosby-Year Book 1998; pp. 1005-16.
3. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15: 21-25.
4. Varjonen E, Kalimo K, Lammintausta K, Terho P. Prevalence of atopic disorders among adolescents in Turku, Finland. Allergy 1992; 47: 243-48.
5. Smith JM. A five-year prospective survey of rural children with asthma and hay fever. J Allergy 1971; 47: 23-30.
6. Togias A, Naclerio RM, Proud D, et al. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol 1988; 81: 782-90.
7. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494-507.
8. Molgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007; 62: 1003-7.
9. Jacobs R, Lieberman P, Kent E, et al. Weather/temperaturesensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc 2009; 30: 120-27.
10. Fokkens WJ. Thoughts on the pathophysiology of non-allergic rhinitis. Curr Allergy Asthma Rep 2002; 2: 203-09.
11. Riedl, MA. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep 2008; 8: 139-46.
12. Settipane RA, Charnock DR. Epidemiology of rhinitis: Allergic and nonallergic. In: Baraniuk JN, Shusterman D, Eds. Nonallergic rhinitis. New York: Informa Healthcare 2007.
13. Shusterman D. Environmental nonallergic rhinitis. In: Baraniuk JN, Shusterman D, Eds. Nonallergic rhinitis. New York: Informa Healthcare 2007.
14. Riechelmann H, Rettinger G, Weschta M, et al. Effects of lowtoxicity particulate matter on human nasal function. J Occup Environ Med 2003; 45: 54-60.
15. FDA Draft Guidance for Allergic Rhinitis: Clinical Development Programs for Drug Products, April 2000. Assessed June 21, 2010 http://www.fda.gov/cder/guidance/2718dft.pdf